Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

23
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
23
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

6.0K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.0K
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

59
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
59
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

13
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
13
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

19
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
19

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut Microbiome Dysbiosis in Metabolic Syndrome: Current Evidence and Emerging Perspectives.

Nutrients·2026
Same author

Impact of a Lifestyle Intervention on Gut Microbiome Composition: A Quasi-Controlled Before-and-After Analysis.

Metabolites·2025
Same author

Dihydrolipoic acid improves diabetic endothelial cell function via the H<sub>2</sub>S-producing enzyme 3-mercaptopyruvate sulfurtransferase.

FEBS letters·2025
Same author

From tear to repair: transcriptomic signatures related to rotator cuff tendon healing outcomes: a prospective clinical and laboratory study.

Journal of shoulder and elbow surgery·2025
Same author

Adipose tissue protein kinase D: regulation of signaling networks and its sex-dependent effects on metabolism.

American journal of physiology. Endocrinology and metabolism·2025
Same author

Loosening the Lid on Shoulder Osteoarthritis: How the Transcriptome and Metabolic Syndrome Correlate with End-Stage Disease.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Apr 28, 2026

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

10.7K

Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action.

Sheree D Martin1, Shona Morrison1, Nicky Konstantopoulos1

  • 1Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Australia.

Molecular Metabolism
|June 20, 2014
PubMed
Summary

Mitochondrial dysfunction can cause insulin resistance in fat cells but not liver cells, showing cell-specific effects. The exact mechanism of mitochondrial impairment, not just ROS production, is key to understanding insulin action.

Keywords:
AMPK, AMP-activated protein kinaseAS160, Akt substrate of 160 kDaAdipocyteBSA, bovine serum albuminECAR, extracellular acidification rateFoxO1, forkhead box protein O1G.O., glucose oxidaseGLUT4, facilitative glucose transporter isoform 4GP, glucose productionHI-FBS, heat-inactivated foetal bovine serumHepatocyteIRS1, insulin receptor substrate 1Insulin actionLDH, lactate dehydrogenaseMMP, mitochondrial membrane potentialMitochondriaMnTBAP, manganese (III) tetrakis (4-benzoic acid) porphyrin chloridePI3K, phosphatidylinositol 3-kinaseROS, reactive oxygen speciesReactive oxygen speciesSOD, superoxide dismutaseT2D, type 2 diabetesTNFα, tumour necrosis factor alpha

More Related Videos

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

10.8K
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

3.7K

Related Experiment Videos

Last Updated: Apr 28, 2026

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

10.7K
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

10.8K
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

3.7K

Area of Science:

  • Metabolic research
  • Cellular biology
  • Mitochondrial function

Background:

  • Mitochondrial dysfunction's role in insulin resistance is debated.
  • Some models show mitochondrial dysfunction causes insulin resistance, while others do not.
  • This suggests complex regulation of insulin action by mitochondria.

Purpose of the Study:

  • To investigate whether mitochondrial dysfunction is necessary or sufficient for insulin resistance.
  • To determine if the cell type and mechanism of mitochondrial impairment affect insulin resistance.
  • To reconcile conflicting findings in metabolic research.

Main Methods:

  • Utilized cellular models to study insulin resistance.
  • Induced mitochondrial dysfunction through various mechanisms.
  • Assessed insulin sensitivity in adipocytes and hepatocytes.

Main Results:

  • Mitochondrial dysfunction is not required for cellular insulin resistance.
  • Impaired mitochondrial function is sufficient to cause insulin resistance in adipocytes.
  • Impaired mitochondrial function has no effect or improves insulin sensitivity in hepatocytes.
  • The mechanism of mitochondrial impairment, not mitochondrial ROS, determined the effect on insulin action.

Conclusions:

  • Mitochondrial dysfunction's impact on insulin resistance is cell-type specific.
  • The mechanism of mitochondrial impairment is crucial for its effect on insulin action.
  • These findings explain contradictory results and highlight the complexity of mitochondrial regulation of insulin sensitivity.